BIOXIS Pharmaceuticals

BIOXIS Pharmaceuticals est membre de Lyonbiopôle

General information

317 avenue Jean Jaures

69007 Lyon

Incorporated in: 2010/09/13

Number of employees: 10


More information

 

Main activity

The Pharmaceutical Company that's Bringing Out the Next Generation of Dermal Fillers. Here at Bioxis Pharmaceuticals, we have created biomaterial scaffolds that help regenerate tissues, improve patient outcomes, and provide better healthcare opportunities for doctors. We are focused on developing medical devices based on patented biomaterials technology with potentially accelerated pathways to market. Our lead medical device candidate MTI-12 is currently at the pre-clinical stage for aesthetic indications; and our hyaluronic acid-based dermal filler brand, CYTOSIAL, has established into exclusive distribution agreements with distributors in Europe and Asia.                            


Funding

Private funding obtained: €3 Million

Public funding obtained: ADI - BPI France CIR

Segmentation
Activities
Products / Services / Technologies
Partnership opportunities / Licensing

Strategic area of application
Medical Technologies


Application market
Dermatology & Cosmetology - Wound healing


Activities
Medical device - Technology provider


Technologies
Biomatarials - Disposable & Implants - Regenerative medicine